Semaglutide 10 mg

Semaglutide (10mg) – Long-Acting GLP-1 Receptor Agonist

Investigate targeted incretin signaling with Semaglutide, a long-acting synthetic analog of human glucagon-like peptide-1 (GLP-1). Engineered with key structural modifications for extended biological half-life, Semaglutide is widely researched for its influence on glucose-dependent insulin secretion, central appetite regulation, delayed gastric emptying, and metabolic efficiency.

Key Benefits:

• Supports Appetite Suppression & Satiety: Acts on central nervous system pathways to reduce hunger signals and caloric intake.
• Promotes Glycemic Control: Stimulates glucose-dependent insulin secretion while inhibiting glucagon release.
• Delays Gastric Emptying: Slows gastrointestinal motility to support sustained glucose regulation.
• Supports Weight & Metabolic Research: Widely evaluated for fat mass reduction and cardiovascular metabolic support.

Ideal For:

• GLP-1 receptor signaling studies
• Weight loss and satiety mechanism research
• Glycemic control and insulin sensitivity modeling
• Cardiometabolic health and fat loss research

Typical research dosing ranges from 0.25 mg to 2.4 mg per week (administered once weekly).

Add 2mL of bacteriostatic water to get a solution that is 5mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 0.5mg of Semaglutide.

Store unmixed vials in a cool, dark place away from direct light. Once reconstituted, this product must be refrigerated between 2°C – 8°C (36°F – 46°F) and used within 30 days.